Satoshi Higasa

Medical Director
Department of Hematology, Hyogo College of Medicine Hospital, Nishinomiya, Japan

Presentation(s):

• OC 40.2 - Efficacy, Safety, and Pharmacokinetics of Emicizumab Prophylaxis in Patients with Acquired Hemophilia A: Primary Analysis Results from a Phase III Study (AGEHA)

  Monday, July 11, 2022
  3:00 PM – 3:15 PM

• VPB0693 - First year report of the multicenter prospective cohort study on ischemic events in adult patients with hemophilia (ADVANCE Japan)

  Monday, July 11, 2022
  6:30 PM – 7:30 PM